Stockreport

Pfizer reports data from Phase II multiple myeloma treatment trial [Yahoo! Finance]

Pfizer, Inc.  (PFE) 
Last pfizer, inc. earnings: 4/28 06:45 am Check Earnings Report
PDF ELREXFIO is a B-cell maturation antigen (BCMA)-cluster of differentiation (CD)3-directed bispecific antibody immunotherapy delivered subcutaneously. The non-randomise [Read more]